Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers

NCT02222506
completednot_applicable

Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers

NCT02222467
completednot_applicable

Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers

NCT02222454
completedphase_3

A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne

NCT01584674

Clinical Trials (4)

Showing 4 of 4 trials
NCT02222506Not Applicable

Safety Evaluation of the KLOX BioPhotonic System in Diabetic Foot Ulcers

Completed
NCT02222467Not Applicable

Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers

Completed
NCT02222454Not Applicable

Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers

Completed
NCT01584674Phase 3

A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4